These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23697266)

  • 21. CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma.
    Shi Y; Gong HL; Zhou L; Tian J; Wang Y
    ORL J Otorhinolaryngol Relat Spec; 2012; 74(2):78-85. PubMed ID: 22354323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship of matrilysin with invasion, metastasis, and prognosis in laryngeal cancer].
    Sun YN; Li Y; Xie MQ; Jin DJ; Li P
    Ai Zheng; 2004 May; 23(5):589-92. PubMed ID: 15142461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
    Kosunen A; Pirinen R; Ropponen K; Pukkila M; Kellokoski J; Virtaniemi J; Sironen R; Juhola M; Kumpulainen E; Johansson R; Nuutinen J; Kosma VM
    Oral Oncol; 2007 Jan; 43(1):51-9. PubMed ID: 16798062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between expression of cellular retinol-binding protein 1 and its methylation status in larynx cancer.
    Peralta R; Valdivia A; Alvarado-Cabrero I; Gallegos F; Apresa T; Hernández D; Mendoza M; Romero P; Paniagua L; Ibáñez M; Cabrera L; Salcedo M
    J Clin Pathol; 2012 Jan; 65(1):46-50. PubMed ID: 22049223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy.
    Cho EI; Kowalski DP; Sasaki CT; Haffty BG
    Laryngoscope; 2004 Nov; 114(11):2001-8. PubMed ID: 15510031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
    de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
    Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may reflect increased tumor invasiveness.
    Culhaci N; Metin K; Copcu E; Dikicioglu E
    BMC Cancer; 2004 Aug; 4():42. PubMed ID: 15291964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
    Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
    J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
    Nart D; Yaman B; Yilmaz F; Zeytunlu M; Karasu Z; Kiliç M
    Liver Transpl; 2010 May; 16(5):621-30. PubMed ID: 20440771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
    Miyata Y; Kanda S; Nomata K; Hayashida Y; Kanetake H
    Urology; 2004 Mar; 63(3):602-8. PubMed ID: 15028476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma.
    Teknos TN; Cox C; Barrios MA; Chepeha DB; Bradford CR; Fisher SG; Wolf GT
    Laryngoscope; 2002 May; 112(5):844-51. PubMed ID: 12150616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telomerase activity is upregulated in laryngeal squamous cell carcinoma.
    Curran AJ; Gullane PJ; Irish J; Macmillan C; Freeman J; Kamel-Reid S
    Laryngoscope; 2000 Mar; 110(3 Pt 1):391-6. PubMed ID: 10718425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients.
    Yorioka CW; Coletta RD; Alves F; Nishimoto IN; Kowalski LP; Graner E
    Int J Oncol; 2002 Jan; 20(1):189-94. PubMed ID: 11743663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic role of MMP-9 expression in head and neck carcinoma patients treated with radiotherapy or chemoradiotherapy.
    Virós D; Camacho M; Zarraonandia I; García J; Quer M; Vila L; León X
    Oral Oncol; 2013 Apr; 49(4):322-5. PubMed ID: 23122824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
    Lee JI; Jin BH; Kim MA; Yoon HJ; Hong SP; Hong SD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):678-84. PubMed ID: 19272813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance expression and relationships with endothelin-1, matrix metalloproteinase-9 in the laryngeal carcinoma].
    Lin Y; Zhang J; Liu S; Liu F; Zou J; Zheng M
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 26(6):245-7, 251. PubMed ID: 22675930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome.
    Kerkelä E; Ala-aho R; Klemi P; Grénman S; Shapiro SD; Kähäri VM; Saarialho-Kere U
    J Pathol; 2002 Oct; 198(2):258-69. PubMed ID: 12237887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
    Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
    Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.